Your browser doesn't support javascript.
loading
New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular Targets.
Santos-Laso, Alvaro; Munoz-Garrido, Patricia; Felipe-Agirre, Maialen; Bujanda, Luis; Banales, Jesus M; Perugorria, Maria J.
Afiliação
  • Santos-Laso A; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute, Donostia University Hospital, University of the Basque Country (UPV-EHU), San Sebastian, Spain.
  • Munoz-Garrido P; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Barcelona, Spain.
  • Felipe-Agirre M; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute, Donostia University Hospital, University of the Basque Country (UPV-EHU), San Sebastian, Spain.
  • Bujanda L; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Barcelona, Spain.
  • Banales JM; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
  • Perugorria MJ; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute, Donostia University Hospital, Paseo del Dr. Begiristain s/n, E-20014, San Sebastian, Spain.
Curr Drug Targets ; 18(8): 908-920, 2017.
Article em En | MEDLINE | ID: mdl-25915485

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Biliares / Células Epiteliais / Matriz Extracelular Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Biliares / Células Epiteliais / Matriz Extracelular Idioma: En Ano de publicação: 2017 Tipo de documento: Article